Malignancies induce a general immune response. The tumor micro‑environment consists of a variety of immune cells, such as:
  • T cells
  • NK cells
  • B cells
  • Dendritic cells
  • Macrophages
  • Monocytes

Image from The Johanna Joyce Lab, Memorial Sloan Kettering Cancer Center

Myloid cells are a certain type of immune cell which emanate from stem cells in the bone marrow and travel to the site of the tumor.
Cancer cells impede the normal development of these myeloid cells and subvert their usual function.
Once corrupted by the cancer these cells engage in immune‑suppressive activities, and become known as Myeloid Derived Suppressor Cells (MDSCs). 

Image from OncLive, Myeloid Cell Subtype Attracts Growing Interest as Immune System Target

MDSCs are the subject of ongoing cutting-edge research and have been targeted by the newest immunotherapy drugs.
ITUS has identified certain sub-classes of MDSCs as being diagnostic in nature and has developed proprietary protocols for detecting the cells in the blood of cancer patients.
In addition to MDSCs, ITUS is evaluating sub-classes of other immune cells in its analysis.

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

ITUS Corporation Announces Second Commercial Focus for Cchek™ will be Breast Cancer


ITUS to Ring the NASDAQ Closing Bell on July 5th


ITUS Accelerates Schedule for its CAR T Therapy and Provides Update


Cancer Fact: Breast cancer accounts for 11.9% of cancer incidences worldwide.